“Lead Hopping”. Validation of Topomer Similarity as a Superior Predictor of Similar Biological Activities
Two extensive studies quantifying the ability of topomer shape similarity to forecast a variety of biological similarities are described. In a prospective trial of “lead hopping”, using topomer similarity for virtual screening and queries from the patent literature, biological assays of 308 selected...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 2004-12, Vol.47 (27), p.6777-6791 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6791 |
---|---|
container_issue | 27 |
container_start_page | 6777 |
container_title | Journal of medicinal chemistry |
container_volume | 47 |
creator | Cramer, Richard D Jilek, Robert J Guessregen, Stefan Clark, Stephanie J Wendt, Bernd Clark, Robert D |
description | Two extensive studies quantifying the ability of topomer shape similarity to forecast a variety of biological similarities are described. In a prospective trial of “lead hopping”, using topomer similarity for virtual screening and queries from the patent literature, biological assays of 308 selected compounds (representing 0.03% of those available, per assay type) yielded 11 successful “lead hops” in the 13 assays attempted. The hit rate averaged over all assays was 39% (“activity” defined as inhibition ≥20% at 10 μM), significantly greater than an unexpectedly high negative control hit rate of 15%. The average “Tanimoto 2D fingerprint similarity” between query and “lead hop” structures (0.36) was little more than the Tanimoto similarity between random drug-like structures. Topomer shape and Tanimoto 2D fingerprint similarities were also compared retrospectively, in their tendencies to concentrate together potential and actual drugs reported to belong to the same “activity class”, for twenty classes. Among the most similar 3% of structures (corresponding to “≥0.85 Tanimoto” for these structures), an average of 62% of the topomer similar selection possessed a near neighbor belonging to the same activity class, roughly a one-third superiority over the “Tanimoto ≥ 0.85” selection containing 48% actives in avoiding false positives. Conversely, the least similar 75% of structures contained 0.3% actives for topomer similarity vs 1.0% actives for Tanimoto 2D fingerprint similarity, a 3-fold superiority for topomers in avoiding false negatives. |
doi_str_mv | 10.1021/jm049501b |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67190176</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67190176</sourcerecordid><originalsourceid>FETCH-LOGICAL-a447t-c9c77e728e3a0fb27728bbced27d15b82ce7c948c20a346141d7c21860a252ca3</originalsourceid><addsrcrecordid>eNpt0cFu1DAQBmCrArVL4dAXqHwpUg8pthPH2WO7oixogUq79GpNHKeabRKndoLorQ8CL9cnwWij7oWTR_KnX-PfhJxwdsGZ4B-2LcvmkvHygMy4FCzJCpa9IjPGhEhELtIj8iaELWMs5SI9JEdc5lxKoWakfX76vbJQ0aXre-zunp_-XNBbaLCCAV1HXU03rnet9XSNLTbgcXikECjQ9dhbj87TG28rNEOcop4UvULXuDs00NBLM-BPHNCGt-R1DU2w76bzmPy4_rhZLJPV90-fF5erBLJMDYmZG6WsEoVNgdWlUHEsS2MroSouy0IYq8w8K4xgkGY5z3iljOBFzkBIYSA9Ju93ub13D6MNg24xGNs00Fk3Bp0rPmdc5RGe76DxLgRva917bME_as70v271S7fRnk6hY9naai-nMiM4mwCE-O7aQ2cw7F2eFjL-SHTJzmEY7K-Xe_D3cbFUSb25Wetl8eV29W3B9dd9Lpigt270XezuPwv-Bfy5njE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67190176</pqid></control><display><type>article</type><title>“Lead Hopping”. Validation of Topomer Similarity as a Superior Predictor of Similar Biological Activities</title><source>ACS Publications</source><source>MEDLINE</source><creator>Cramer, Richard D ; Jilek, Robert J ; Guessregen, Stefan ; Clark, Stephanie J ; Wendt, Bernd ; Clark, Robert D</creator><creatorcontrib>Cramer, Richard D ; Jilek, Robert J ; Guessregen, Stefan ; Clark, Stephanie J ; Wendt, Bernd ; Clark, Robert D</creatorcontrib><description>Two extensive studies quantifying the ability of topomer shape similarity to forecast a variety of biological similarities are described. In a prospective trial of “lead hopping”, using topomer similarity for virtual screening and queries from the patent literature, biological assays of 308 selected compounds (representing 0.03% of those available, per assay type) yielded 11 successful “lead hops” in the 13 assays attempted. The hit rate averaged over all assays was 39% (“activity” defined as inhibition ≥20% at 10 μM), significantly greater than an unexpectedly high negative control hit rate of 15%. The average “Tanimoto 2D fingerprint similarity” between query and “lead hop” structures (0.36) was little more than the Tanimoto similarity between random drug-like structures. Topomer shape and Tanimoto 2D fingerprint similarities were also compared retrospectively, in their tendencies to concentrate together potential and actual drugs reported to belong to the same “activity class”, for twenty classes. Among the most similar 3% of structures (corresponding to “≥0.85 Tanimoto” for these structures), an average of 62% of the topomer similar selection possessed a near neighbor belonging to the same activity class, roughly a one-third superiority over the “Tanimoto ≥ 0.85” selection containing 48% actives in avoiding false positives. Conversely, the least similar 75% of structures contained 0.3% actives for topomer similarity vs 1.0% actives for Tanimoto 2D fingerprint similarity, a 3-fold superiority for topomers in avoiding false negatives.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm049501b</identifier><identifier>PMID: 15615527</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Biological and medical sciences ; Computing Methodologies ; Drug Design ; Medical sciences ; Miscellaneous ; Molecular Mimicry ; Molecular Structure ; Pharmacology. Drug treatments ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 2004-12, Vol.47 (27), p.6777-6791</ispartof><rights>Copyright © 2004 American Chemical Society</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a447t-c9c77e728e3a0fb27728bbced27d15b82ce7c948c20a346141d7c21860a252ca3</citedby><cites>FETCH-LOGICAL-a447t-c9c77e728e3a0fb27728bbced27d15b82ce7c948c20a346141d7c21860a252ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm049501b$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm049501b$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16385022$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15615527$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cramer, Richard D</creatorcontrib><creatorcontrib>Jilek, Robert J</creatorcontrib><creatorcontrib>Guessregen, Stefan</creatorcontrib><creatorcontrib>Clark, Stephanie J</creatorcontrib><creatorcontrib>Wendt, Bernd</creatorcontrib><creatorcontrib>Clark, Robert D</creatorcontrib><title>“Lead Hopping”. Validation of Topomer Similarity as a Superior Predictor of Similar Biological Activities</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Two extensive studies quantifying the ability of topomer shape similarity to forecast a variety of biological similarities are described. In a prospective trial of “lead hopping”, using topomer similarity for virtual screening and queries from the patent literature, biological assays of 308 selected compounds (representing 0.03% of those available, per assay type) yielded 11 successful “lead hops” in the 13 assays attempted. The hit rate averaged over all assays was 39% (“activity” defined as inhibition ≥20% at 10 μM), significantly greater than an unexpectedly high negative control hit rate of 15%. The average “Tanimoto 2D fingerprint similarity” between query and “lead hop” structures (0.36) was little more than the Tanimoto similarity between random drug-like structures. Topomer shape and Tanimoto 2D fingerprint similarities were also compared retrospectively, in their tendencies to concentrate together potential and actual drugs reported to belong to the same “activity class”, for twenty classes. Among the most similar 3% of structures (corresponding to “≥0.85 Tanimoto” for these structures), an average of 62% of the topomer similar selection possessed a near neighbor belonging to the same activity class, roughly a one-third superiority over the “Tanimoto ≥ 0.85” selection containing 48% actives in avoiding false positives. Conversely, the least similar 75% of structures contained 0.3% actives for topomer similarity vs 1.0% actives for Tanimoto 2D fingerprint similarity, a 3-fold superiority for topomers in avoiding false negatives.</description><subject>Biological and medical sciences</subject><subject>Computing Methodologies</subject><subject>Drug Design</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Molecular Mimicry</subject><subject>Molecular Structure</subject><subject>Pharmacology. Drug treatments</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0cFu1DAQBmCrArVL4dAXqHwpUg8pthPH2WO7oixogUq79GpNHKeabRKndoLorQ8CL9cnwWij7oWTR_KnX-PfhJxwdsGZ4B-2LcvmkvHygMy4FCzJCpa9IjPGhEhELtIj8iaELWMs5SI9JEdc5lxKoWakfX76vbJQ0aXre-zunp_-XNBbaLCCAV1HXU03rnet9XSNLTbgcXikECjQ9dhbj87TG28rNEOcop4UvULXuDs00NBLM-BPHNCGt-R1DU2w76bzmPy4_rhZLJPV90-fF5erBLJMDYmZG6WsEoVNgdWlUHEsS2MroSouy0IYq8w8K4xgkGY5z3iljOBFzkBIYSA9Ju93ub13D6MNg24xGNs00Fk3Bp0rPmdc5RGe76DxLgRva917bME_as70v271S7fRnk6hY9naai-nMiM4mwCE-O7aQ2cw7F2eFjL-SHTJzmEY7K-Xe_D3cbFUSb25Wetl8eV29W3B9dd9Lpigt270XezuPwv-Bfy5njE</recordid><startdate>20041230</startdate><enddate>20041230</enddate><creator>Cramer, Richard D</creator><creator>Jilek, Robert J</creator><creator>Guessregen, Stefan</creator><creator>Clark, Stephanie J</creator><creator>Wendt, Bernd</creator><creator>Clark, Robert D</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041230</creationdate><title>“Lead Hopping”. Validation of Topomer Similarity as a Superior Predictor of Similar Biological Activities</title><author>Cramer, Richard D ; Jilek, Robert J ; Guessregen, Stefan ; Clark, Stephanie J ; Wendt, Bernd ; Clark, Robert D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a447t-c9c77e728e3a0fb27728bbced27d15b82ce7c948c20a346141d7c21860a252ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Biological and medical sciences</topic><topic>Computing Methodologies</topic><topic>Drug Design</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Molecular Mimicry</topic><topic>Molecular Structure</topic><topic>Pharmacology. Drug treatments</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cramer, Richard D</creatorcontrib><creatorcontrib>Jilek, Robert J</creatorcontrib><creatorcontrib>Guessregen, Stefan</creatorcontrib><creatorcontrib>Clark, Stephanie J</creatorcontrib><creatorcontrib>Wendt, Bernd</creatorcontrib><creatorcontrib>Clark, Robert D</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cramer, Richard D</au><au>Jilek, Robert J</au><au>Guessregen, Stefan</au><au>Clark, Stephanie J</au><au>Wendt, Bernd</au><au>Clark, Robert D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>“Lead Hopping”. Validation of Topomer Similarity as a Superior Predictor of Similar Biological Activities</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2004-12-30</date><risdate>2004</risdate><volume>47</volume><issue>27</issue><spage>6777</spage><epage>6791</epage><pages>6777-6791</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Two extensive studies quantifying the ability of topomer shape similarity to forecast a variety of biological similarities are described. In a prospective trial of “lead hopping”, using topomer similarity for virtual screening and queries from the patent literature, biological assays of 308 selected compounds (representing 0.03% of those available, per assay type) yielded 11 successful “lead hops” in the 13 assays attempted. The hit rate averaged over all assays was 39% (“activity” defined as inhibition ≥20% at 10 μM), significantly greater than an unexpectedly high negative control hit rate of 15%. The average “Tanimoto 2D fingerprint similarity” between query and “lead hop” structures (0.36) was little more than the Tanimoto similarity between random drug-like structures. Topomer shape and Tanimoto 2D fingerprint similarities were also compared retrospectively, in their tendencies to concentrate together potential and actual drugs reported to belong to the same “activity class”, for twenty classes. Among the most similar 3% of structures (corresponding to “≥0.85 Tanimoto” for these structures), an average of 62% of the topomer similar selection possessed a near neighbor belonging to the same activity class, roughly a one-third superiority over the “Tanimoto ≥ 0.85” selection containing 48% actives in avoiding false positives. Conversely, the least similar 75% of structures contained 0.3% actives for topomer similarity vs 1.0% actives for Tanimoto 2D fingerprint similarity, a 3-fold superiority for topomers in avoiding false negatives.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>15615527</pmid><doi>10.1021/jm049501b</doi><tpages>15</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2004-12, Vol.47 (27), p.6777-6791 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_67190176 |
source | ACS Publications; MEDLINE |
subjects | Biological and medical sciences Computing Methodologies Drug Design Medical sciences Miscellaneous Molecular Mimicry Molecular Structure Pharmacology. Drug treatments Structure-Activity Relationship |
title | “Lead Hopping”. Validation of Topomer Similarity as a Superior Predictor of Similar Biological Activities |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T21%3A04%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E2%80%9CLead%20Hopping%E2%80%9D.%20Validation%20of%20Topomer%20Similarity%20as%20a%20Superior%20Predictor%20of%20Similar%20Biological%20Activities&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Cramer,%20Richard%20D&rft.date=2004-12-30&rft.volume=47&rft.issue=27&rft.spage=6777&rft.epage=6791&rft.pages=6777-6791&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm049501b&rft_dat=%3Cproquest_cross%3E67190176%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67190176&rft_id=info:pmid/15615527&rfr_iscdi=true |